About: Fast Accurate Point of Care COVID-19 Pandemic Diagnosis Enabled Through Advanced Lab-on-a-Chip Optical Biosensors: Opportunities and Challenges

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Fast Accurate Point of Care COVID-19 Pandemic Diagnosis Enabled Through Advanced Lab-on-a-Chip Optical Biosensors: Opportunities and Challenges Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Fast Accurate Point of Care COVID-19 Pandemic Diagnosis Enabled Through Advanced Lab-on-a-Chip Optical Biosensors: Opportunities and Challenges
Creator	Wang, Chao Chen, Ray Asghari, Aref Dalir, Hamed Yoo, Kyoung
Source	ArXiv
abstract	The sudden rise of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic early 2020 throughout the world has called into drastic action measures to do instant detection and reduce the spread rate. The common diagnostics testing methods has been only partially effective in satisfying the booming demand for fast detection methods to contain the further spread. However, the point-of-risk accurate diagnosis of this new emerging viral infection is paramount as simultaneous normal working operation and dealing with symptoms of SARS-CoV-2 can become the norm for years to come. Sensitive cost-effective biosensor with mass production capability is crucial throughout the world until a universal vaccination become available. Optical label-free biosensors can provide a non-invasive, extremely sensitive rapid detection technique up to ~1 fM concentration along with few minutes sensing. These biosensors can be manufactured on a mass-scale (billions) to detect the COVID-19 viral load in nasal, saliva, urinal, and serological samples even if the infected person is asymptotic. Methods investigated here are the most advanced available platforms for biosensing optical devices resulted from the integration of state-of-the-art designs and materials. These approaches are including but not limited to integrated optical devices, plasmonic resonance and also emerging nanomaterial biosensors. The lab-on-a-chip platforms examined here are suitable not only for SARS-CoV-2 spike protein detection but also other contagious virions such as influenza, and middle east respiratory syndrome (MERS).
has issue date	2020-08-01(xsd:dateTime)
has license	arxiv
sha1sum (hex)	e2930e630933e6fabddd00369308f8250a18a187
resource representing a document's title	Fast Accurate Point of Care COVID-19 Pandemic Diagnosis Enabled Through Advanced Lab-on-a-Chip Optical Biosensors: Opportunities and Challenges
resource representing a document's body	covid:e2930e630933e6fabddd00369308f8250a18a187#body_text
is schema:about of	covid:arg/e2930e630933e6fabddd00369308f8250a18a187 named entity 'SARS-CoV-2' named entity 'MERS' named entity 'middle east respiratory syndrome' named entity 'biosensors' named entity 'influenza' named entity 'COVID-19' named entity 'nanomaterial' named entity 'graphene' named entity 'biomolecules' named entity 'π stacking' named entity 'nonlinear optical' named entity 'graphene' named entity 'high-throughput' named entity 'virus-like particle' named entity 'bend radius' named entity 'incident angle' named entity 'FSR' named entity 'pneumonia' named entity 'black phosphorus' named entity 'diagnostic tools' named entity 'photoluminescence' named entity 'clinical diagnosis' named entity 'single stranded RNA virus' named entity 'organics' named entity 'detection limit' named entity 'pathogens' named entity 'destructive interference' named entity 'FSR' named entity 'saliva' named entity 'mid-infrared spectroscopy' named entity 'virus' named entity 'ribonucleic acid' named entity 'photonic crystal' named entity 'living cells' named entity 'neutralizing antibodies' named entity 'aqueous solution' named entity 'ICP-OES' named entity 'surface plasmons' named entity 'RT-PCR' named entity 'disinfection' named entity 'biomolecules' named entity 'absorption spectroscopy' named entity 'absorption coefficient' named entity 'urine' named entity 'specialty training' named entity 'extinction ratio' named entity 'serological' named entity 'infection' named entity 'biomolecules' named entity 'infusion' named entity 'COVID' named entity 'coronavirus' named entity 'virus' named entity 'miRNA' named entity 'graphene' named entity 'Graphene' named entity 'SARS-CoV-2' named entity 'refractive index' named entity 'MZI' named entity 'graphene' named entity 'electromagnetic waves' named entity 'optical emission spectrometry' named entity 'SARS-CoV-2' named entity 'Graphene oxide' named entity '1.14' named entity 'antigen' named entity 'phase matching' named entity 'group velocity' named entity 'SARS-CoV-2' named entity 'analyte' named entity 'ACE2' named entity 'graphene' named entity 'molecule' named entity 'virus' named entity 'biomarkers' named entity 'membrane protein' named entity 'Vahala' named entity 'anti-body' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'virus' named entity 'biosensor'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software